Influenza vaccines | Tenderlake

Influenza vaccines

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
15 May 2019
Closing Date:
28 May 2019
Location(s):
ES300 Madrid (ES Spain/ESPAÑA)
Description:
Framework Agreement selection of suppliers of seasonal influenza vaccines for certain contracting bodies of AGE, INGESA and the cities of Ceuta and Melilla and several Autonomous Communities

Framework Agreement selection of suppliers of seasonal influenza vaccines for certain contracting bodies of AGE, INGESA and the cities of Ceuta and Melilla and several Autonomous Communities.


Inactivated vaccines, produced from viruses grown in embryonated eggs of fractionated viruses or surface antigens (H and N), or similar containing 3 strains of influenza virus

Inactivated vaccines, produced from viruses grown in embryonated eggs of fractionated viruses or surface antigens (H and N), or similar containing 3 strains of influenza virus.


Inactivated vaccines produced from viruses grown in embryonated eggs of fractionated viruses or surface antigens (H and N), or similar containing 4 strains of influenza virus

Inactivated vaccines produced from viruses grown in embryonated eggs of fractional viruses or surface antigens (H and N), or similar containing 4 strains of influenza virus.


Inactivated vaccines produced from virus grown in embryonated eggs, 15 micrograms of hemagglutinin, with adjuvant or similar

Inactivated vaccines produced from viruses grown in embryonated eggs, of 15 micrograms of hemagglutinin, with adjuvant or similar.


Inactivated vaccines produced from virus grown in cell cultures, fractionated virgins or surface antigens (H and N) or similar

Inactivated vaccines produced from virus grown in cell cultures, fractionated viruses or surface antigens (H and N) or similar.

Download full details as .pdf
The Buyer:
Subsecretaría de Sanidad, Servicios Sociales e Igualdad
CPV Code(s):
33651660 - Influenza vaccines